Myeloma is a malignant and incurable disease of the bone marrow. In up to a fifth of patients it is found by chance.
We have a large and well-established myeloma service. The team has vast experience in dealing with myeloma and associated problems at all stages of the disease. We offer a full range of treatment approaches and have an extensive clinical trials portfolio which allows access to newer therapies such as monoclonal antibodies.
We also have an active clinical research programme with particular interest in imaging approaches, diagnostic markers and immunotherapy.